IMAC

IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

IMAC Holdings Adds Regenerative Wound Care Service in Regeneration Centers

IMAC Holdings Celebrates One-Year Anniversary of Health Maintenance Plans Surpassing 1,000 Members and Demonstrating Increased Demand for Spinal Wellness Among Its IMAC Regeneration Center Customers

IMAC Holdings Expands Florida Presence to Orlando Following Acquisition of Synergy Healthcare

IMAC Stock Price Increases 23.97%: Why It Happened

IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson's Disease

IMAC Holdings Receives Forgiveness of $1.69 Million PPP Loan